Herman Mielants

Herman Mielants's AcademicInfluence.com Rankings

Herman Mielants

Philosophy

#7797

World Rank

#11054

Historical Rank

Logic

#4834

World Rank

#6163

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Herman Mielants's Degrees

PhD Rheumatology Ghent University
Doctorate Medicine Ghent University

Why Is Herman Mielants Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Herman Mielants's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Classification criteria for psoriatic arthritis: development of new criteria from a large international study. (2006) (2873)
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection (2009) (2650)
HL-A AND INFECTIVE SACROILEITIS (1974) (2104)
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal (2009) (780)
Assessment of enthesitis in ankylosing spondylitis (2003) (570)
New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS) (2009) (510)
Letter: HL-A and infective sacroileitis. (1974) (483)
Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative (2008) (464)
What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter. (2004) (372)
Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy. (2002) (362)
Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations (2004) (350)
Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. (1999) (326)
Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor α (infliximab) in spondyloarthropathy: an open pilot study (2000) (311)
The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. (1995) (272)
Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. (2000) (258)
Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity (2000) (248)
Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine (2008) (236)
Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model (2012) (231)
Crohn's disease associated with spondyloarthropathy: effect of TNF-α blockade with infliximab on articular symptoms (2000) (227)
Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries (2002) (215)
Ankylosing spondylitis and bowel disease. (2002) (206)
Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease? (2003) (197)
Long-term evolution of gut inflammation in patients with spondyloarthropathy. (1996) (194)
Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study. (2001) (193)
Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. (1990) (193)
Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? (1999) (192)
The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. (1995) (188)
Ileocolonoscopic findings in seronegative spondylarthropathies. (1988) (176)
Histopathology of intestinal inflammation related to reactive arthritis. (1987) (173)
Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. (2007) (173)
Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation? (2005) (154)
Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy (2005) (150)
Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis (2009) (149)
Ileocolonoscopy in seronegative spondylarthropathy. (1989) (149)
HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis. (1985) (141)
Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study (2011) (139)
Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study. (1991) (136)
Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis (2005) (135)
The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice (2007) (130)
Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. (2005) (129)
Radiological scoring methods in ankylosing spondylitis. Reliability and change over 1 and 2 years. (2004) (128)
Repeated infusions of infliximab, a chimeric anti-TNFα monoclonal antibody, in patients with active spondyloarthropathy: one year follow up (2002) (128)
Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists. (2008) (125)
Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from the GIANT cohort (2013) (124)
Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries (2003) (116)
Bowel inflammation and the spondyloarthropathies. (1998) (115)
Course of gut inflammation in spondylarthropathies and therapeutic consequences. (1996) (102)
Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study (2012) (101)
Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFα (2001) (100)
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment (2005) (96)
Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies. (2005) (94)
Gut inflammation in psoriatic arthritis: a prospective ileocolonoscopic study. (1995) (93)
CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn’s disease (2004) (89)
Colon mucosa of patients both with spondyloarthritis and Crohn’s disease is enriched with macrophages expressing the scavenger receptor CD163 (2004) (89)
Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy (2004) (85)
Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn’s disease (2004) (84)
Determinants of hyperkyphosis in patients with ankylosing spondylitis (2005) (84)
The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects. (1995) (81)
The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. (2004) (78)
Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy (2003) (76)
Gut inflammation and spondyloarthropathies (2002) (75)
Gut inflammation in children with late onset pauciarticular juvenile chronic arthritis and evolution to adult spondyloarthropathy--a prospective study. (1993) (75)
A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis. (1999) (74)
Radiological scoring methods in ankylosing spondylitis: reliability and sensitivity to change over one year. (1999) (74)
Costs of ankylosing spondylitis in three European countries: the patient’s perspective (2003) (74)
Interpretation of ileal biopsies: morphological features in normal and diseased mucosa (2001) (72)
Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease. (1991) (72)
Enrichment of T cells carrying beta7 integrins in inflamed synovial tissue from patients with early spondyloarthropathy, compared to rheumatoid arthritis. (1998) (66)
Interferon gamma in rheumatoid arthritis--a double blind study comparing human recombinant interferon gamma with placebo. (1988) (64)
Focal up-regulation of E-cadherin-catenin complex in inflamed bowel mucosa but reduced expression in ulcer-associated cell lineage. (2000) (63)
Extra-articular manifestations. (2009) (61)
Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy (2001) (61)
Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity (2006) (60)
Clinical and genetic factors associated with sacroiliitis in Crohn's disease (2007) (60)
Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex (2000) (59)
M‐cells are damaged and increased in number in inflamed human ileal mucosa (1993) (59)
Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab. (2006) (58)
Spinal Radiographic Changes in Ankylosing Spondylitis: Association with Clinical Characteristics and Functional Outcome (2009) (57)
An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis (2006) (57)
Clinical survey of and pathogenic approach to para-articular ossifications in long-term coma. (1975) (57)
Anti-tumour necrosis factor α therapy for ankylosing spondylitis: international experience (2002) (56)
Scoring of radiographic progression in randomised clinical trials in ankylosing spondylitis: a preference for paired reading order (2004) (56)
A prospective study of patients with spondyloarthropathy with special reference to HLA-B27 and to gut histology. (1993) (54)
A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis (2004) (54)
The gut in the spondyloarthropathies. (1990) (54)
HLA antigens in seronegative spondylarthropathies. Reactive arthritis and arthritis in ankylosing spondylitis: relation to gut inflammation. (1987) (50)
Involvement of the zygapophyseal joint in ankylosing spondylitis: relation to the bridging syndesmophyte. (1999) (50)
ASAS/EULAR recommendations for the management of ankylosing spondylitis: the patient version (2008) (49)
The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome (2001) (49)
HLA-B27 related arthritis and bowel inflammation. Part 1. Sulfasalazine (salazopyrin) in HLA-B27 related reactive arthritis. (1985) (49)
The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis. (2006) (45)
Increase in lymphoid follicles and leukocyte adhesion molecules emphasizes a role for the gut in spondyloarthropathy pathogenesis (2002) (45)
Repeat ileocolonoscopy in reactive arthritis. (1987) (44)
Outcome variables in ankylosing spondylitis: evaluation of their relevance and discriminant capacity. (1999) (43)
Subclinical involvement of the gut in undifferentiated spondylarthropathies. (1989) (43)
Salicylate-induced gastrointestinal bleeding: comparison between soluble buffered, enteric-coated, and intravenous administration. (1979) (42)
Prevalence of inflammatory rheumatic diseases in an adolescent urban student population, age 12 to 18, in Belgium. (1993) (41)
LEVAMISOLE-INDUCED ADVERSE REACTIONS IN HLA B27-POSITIVE RHEUMATOID ARTHRITIS (1978) (41)
Letter: Levamisole in rheumatoid arthritis. (1976) (41)
How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis? (2007) (40)
Distinctive activated cellular subsets in colon from patients with Crohn's disease and ulcerative colitis. (1998) (39)
Chemical agents and enzymes used for the extraction of gut lymphocytes influence flow cytometric detection of T cell surface markers. (2000) (39)
Cervical spine involvement in rheumatoid arthritis: a clinical, neurological and radiological evaluation. (1994) (39)
Intestinal mucosal permeability in inflammatory rheumatic diseases (1992) (38)
Gout and its relation to lipid metabolism. I. Serum uric acid, lipid, and lipoprotein levels in gout. (1973) (38)
Late onset pauciarticular juvenile chronic arthritis: relation to gut inflammation. (1987) (38)
Successful use of infliximab in a patient with treatment resistant spondyloarthropathy related uveitis (2002) (38)
Measurement of spinal mobility in ankylosing spondylitis: comparison of occiput-to-wall and tragus-to-wall distance. (2004) (38)
Sulfasalazine treatment in juvenile chronic arthritis: an open study. (1991) (37)
Mucosal Inflammation in Spondylarthritides: Past, Present, and Future (2011) (36)
Gut inflammation in the spondyloarthropathies (2005) (36)
Intestinal mucosal permeability in inflammatory rheumatic diseases. I. Role of antiinflammatory drugs. (1991) (35)
Avascular necrosis and its relation to lipid and purine metabolism. (1975) (34)
Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: international experience. (2002) (34)
A cross‐sectional study on the prevalence of metabolic syndrome in psoriasis compared to psoriatic arthritis (2014) (34)
Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope (2006) (34)
Altered gut transcriptome in spondyloarthropathy (2006) (33)
The zygapophyseal joint determines morphology of the enthesophyte. (2000) (33)
Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis (1982) (32)
Sustained response to tocilizumab in a patient with relapsing polychondritis with aortic involvement: a case based review (2014) (32)
The efficacy and toxicity of a constant low dose of methotrexate as a treatment for intractable rheumatoid arthritis: an open prospective study. (1991) (32)
CARD15 polymorphisms are associated with anti‐Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients (2005) (32)
Understanding Limitations in At-work Productivity in Patients with Active Ankylosing Spondylitis: The Role of Work-related Contextual Factors (2015) (31)
Diagnostic performance and predictive value of rheumatoid factor, anti-citrullinated peptide antibodies, and the HLA shared epitope for diagnosis of rheumatoid arthritis. (2005) (31)
Major histocompatibility complex class II antigen (HLA-DR) expression by ileal epithelial cells in patients with seronegative spondylarthropathy. (1990) (30)
The role of gut inflammation in the pathogenesis of spondyloarthropathies. (1996) (30)
Immune linkages between inflammatory bowel disease and spondyloarthropathies. (2002) (30)
Interactions between gut inflammation and arthritis/spondylitis (2010) (30)
A study of the hematological side effects of levamisole in rheumatoid arthritis with recommendations. (1978) (28)
Destructive lesions of small joints in seronegative spondylarthropathies: relation to gut inflammation. (1990) (28)
Immunoglobulin containing cells in terminal ileum and colorectum of patients with arthritis related gut inflammation. (1988) (27)
Candida Glabrata Arthritis: Case Report and Review of the Literature of Candida Arthritis (1999) (27)
AGRANULOCYTOSIS, LEVAMISOLE, AND HLA-B27 (1977) (26)
Healthcare consumption and direct costs of rheumatoid arthritis in Belgium (2005) (26)
Expression of T cell receptors αβ and γδ in the ileal mucosa of patients with Crohn's disease and with spondylarthropathy (1992) (25)
Altered expression of alpha E beta 7 integrin on intra-epithelial and lamina propria lymphocytes in patients with Crohn's disease. (1998) (24)
INFLAMMATION OF THE ILEUM IN PATIENTS WITH B27-POSITIVE REACTIVE ARTHRITIS (1984) (24)
Gut mucosal T cell lines from ankylosing spondylitis patients are enriched with alphaEbeta7 integrin. (2001) (24)
Comparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo (2006) (23)
Levamisole as basic treatment of rheumatoid arthritis: longterm evaluation. (1981) (23)
Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor α (2001) (23)
Long-term functional results of the non-surgical treatment of common bacterial infections of joints. (1982) (22)
Idiopathic inflammatory bowel diseases: immunological hypothesis. (1994) (22)
Comparison of serum salicylate levels and gastro-intestinal blood loss between salsalate (Disalcid)and other forms of salicylates. (1981) (22)
Infliximab in patients who have spondyloarthropathy: clinical efficacy, safety, and biological immunomodulation. (2003) (22)
CARD 15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn ’ s disease (2004) (22)
The intimate relationship between gut and joint in spondyloarthropathies (2007) (21)
Non-Hodgkin's lymphoma presenting with spinal involvement (2000) (20)
Review article: bone and joint diseases in inflammatory bowel disease. (1998) (20)
M-cells are damaged and increased in number in inflamed human ileal mucosa. (1994) (19)
Anti-TNF-alpha therapy in ankylosing spondylitis. (2006) (19)
NSAID AND THE LEAKY GUT (1985) (19)
Association between ankylosing spondylitis and diffuse idiopathic skeletal hyperostosis: reality or fiction? (1996) (19)
LEVAMISOLE IN RHEUMATOID ARTHRITIS (1976) (19)
Leflunomide and methotrexate combination therapy in daily clinical practice (2006) (19)
Destructive hip lesions in seronegative spondyloarthropathies: relation to gut inflammation. (1990) (18)
The gut in ankylosing spondylitis and other spondyloarthropathies: inflammation beneath the surface. (2003) (18)
Experience and recommendations for treatment schedule of levamisole in rheumatoid arthritis. (1978) (18)
HLA and juvenile chronic polyarthritis. (2008) (18)
Opportunities for immune modulation in the spondyloarthropathies with special reference to gut inflammation (2000) (17)
Evaluation of the involvement of axial entheses and sacroiliac joints in relation to diagnosis: Comparison among diffuse idiopathic skeletal hyperostostis (DISH), osteoarthrosis and ankylosing spondylitis (1992) (17)
Rheumatoid factor and serum IgG, IgM and IgA levels in rheumatoid arthritis with vasculitis. (1976) (16)
Bilateral spontaneous pneumothorax in a patient with pulmonary rheumatoid nodules, secondary infected by Aspergillus (2007) (16)
Strontium 87m scanning of the sacroiliac joints in ankylosing spondylitis. (1972) (16)
Subclinical gut inflammation in spondyloarthritis is associated with a pro-angiogenic intestinal mucosal phenotype (2011) (16)
Thymopoietin pentapeptide (thymopentin, TP-5) in the treatment of rheumatoid arthritis. A compilation of several short- and longterm clinical studies. (1984) (16)
A Nationwide Survey on Patient’s versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise Study (2016) (16)
Bone scintigraphy of the hands in early stage lupus erythematosus and rheumatoid arthritis. (1997) (16)
HLA-B27 positive idiopathic acute anterior uveitis: a unique manifestation of subclinical gut inflammation. (1990) (16)
Increased intestinal permeability in ankylosing spondylitis. (1992) (16)
Current use of biologicals for the treatment of spondyloarthropathies (2001) (15)
Is 99mTc human immunoglobulin G scintigraphy (HIG-scan) useful for the detection of spinal inflammation in ankylosing spondylitis? (2000) (15)
Reliability of self assessed joint counts in ankylosing spondylitis (2002) (14)
Gout and its relation to lipid metabolism. II. Correlations between uric acid, lipid, and lipoprotein levels in gout. (1973) (13)
The effect of low doses of prednisolone on T-cell subsets in rheumatoid arthritis. (1987) (13)
Contextual factors influence work outcomes in employed patients with ankylosing spondylitis starting etanercept: 2-year results from AS@Work (2018) (12)
Sulphasalazine (Salazopyrin) in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis (2005) (12)
ILEAL INFLAMMATION IN B27-POSITIVE REACTIVE ARTHRITIS (1984) (12)
Clinical manifestations in HLA-B27-positive patients. (1987) (12)
Peripheral blood T lymphocyte subpopulations determined by monoclonal antibodies in active rheumatoid arthritis. (1986) (12)
Simultaneous occurrence of diffuse idiopathic skeletal hyperostosis and ankylosing spondylitis in the same patient. (1992) (11)
Peripheral blood T lymphocytes subpopulations in HLA-B7 related rheumatic diseases: ankylosing spondylitis and reactive synovitis. (1983) (11)
Disease manifestations of progressive systemic sclerosis: sensitivity and specificity (1987) (11)
Enteropathic arthritis, uveitis, Whipple's disease, and miscellaneous spondyloarthropathies. (1993) (10)
Spondylarthropathies: from gut to target organs. (1996) (10)
Familial aggregation in seronegative spondyloarthritis of enterogenic origin. A family study. (1986) (10)
Are syndesmophytes most prevalent in the lumbar or in the cervical spine in patients with ankylosing spondylitis and do they develop in a specific direction? (2012) (10)
The bowel and spondylarthritis: a clinical approach (1998) (10)
High Prevalence of Undiagnosed Axial Spondyloarthritis in Patients with Chronic Low Back Pain Consulting Non-Rheumatologist Specialists in Belgium: SUSPECT Study (2017) (9)
Influence of the gut and cytokine patterns in spondyloarthropathy. (2002) (9)
Quantitative assessment of foot structure in rheumatoid arthritis by a foot digitizer: Detection of deformities even in the absence of erosions (2012) (9)
Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis. (2004) (9)
Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study. (1987) (9)
BRUCELLAR SPONDYLODISCITIS: CASE REPORT (2007) (8)
Clinical and genetic factors associated with sacroi liitis in Crohn's disease (2008) (8)
Recombinant interferon gamma in rheumatoid arthritis. A double-blind study comparing immuneron (recombinant interferon gamma) with placebo (1988) (8)
Structure-Modifying Capacity of Anti-Tumour Necrosis Factor-α Therapy in Ankylosing Spondylitis (2012) (8)
Changes in antinuclear serology in patients with spondylarthropathy under sulphasalazine treatment. (1993) (8)
CARD15 mutations in patients with spondyloarthropathy are linked with disease progression and evolution to Crohn's disease (2003) (8)
Intervention with immunomodulatory agents: new pharmacological developments (1992) (7)
Polyarteritis Nodosa Mimicking Polymyalgia Rheumatica (1999) (7)
B27 and agranulocytosis in rheumatoid arthritis patients treated with levamisole. (1979) (7)
Current concepts in psoriatic arthritis. (1994) (7)
Spondylarthropathy and gut inflammation: immunopathogenetic mechanisms. (1992) (6)
A challenging case of septic sacroiliitis with psoas involvement (2014) (6)
Gastrointestinal tract and rheumatic disease (1998) (6)
Immunoregulatory changes in autoimmune disease. (1983) (6)
Thymic hormones and interferons in the treatment of rheumatoid arthritis. (1988) (6)
Expression of T cell receptors alpha beta and gamma delta in the ileal mucosa of patients with Crohn's disease and with spondylarthropathy. (1992) (6)
Osteomyelitis in a patient with a chronically infected arterial graft and longstanding hypertrophic osteoarthropathy of the leg. (1991) (6)
Significance of gut inflammation in the seronegative spondyloarthropathies. (1987) (6)
Long-term evolution of patients with spondylarthropathy and gut inflammation (1994) (6)
Sensitivity and specificity of criteria for spondyloarthritis in children with late onset pauciarticular juvenile chronic arthritis as well as their characteristics. (2009) (6)
Clinical and radiographic features of Reiter's syndrome and inflammatory bowel disease related to arthritis. (1990) (6)
[Significance of intestinal inflammation in the pathogenesis of spondylarthropathies]. (1996) (5)
Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists (2010) (5)
Long-term evaluation of intermittent levamisole treatment in rheumatoid arthritis (1977) (5)
OP0056 Tnf-alpha blockade with infliximab in patients with active spondyloarthropathy: follow-up of one year maintenance regimen (2001) (5)
Gut mucosal T cell lines from ankylosing spondylitis patients are enriched with E 7 integrin (2002) (5)
Influence of low dose corticosteroid administration on the lymphocytes subpopulations. (1982) (5)
Spondyloarthropathies: progress and challenges. (2008) (5)
Ileal mucosal mononuclear cells in patients with seronegative spondylarthropathy. (1990) (5)
Macroscopic and histological changes of the ileum HLA-B27 related diseases: therapeutic consequences. (1984) (5)
Increased number of macrophages in non-inflamed colon of patients with spondyloarthropathy, a human model of early Crohn's disease (2000) (5)
B27 and agranulocytosis in rheumatoid arthritis patients treated with levamisole. (1979) (4)
Ileitis in the spondylarthropathies (1997) (4)
Analysis of telomere length as predictive marker in psoriasis for comorbidities (2016) (4)
Reduced metallothionein expression in colonic Crohn's disease: evidence for it new disease-modifying gene (2008) (4)
Clinical observations programme in SpA: disease parameters, treatment options and practical management issues (2008) (4)
Prevalence of clinical and subclinical spondyloarthropathy in patients with inflammatory bowel disease (1998) (4)
Clinical assessment in the spondyloarthropathies. (2009) (4)
The effect of infliximab on skin lesions in a patient with scleroderma (CREST) (2004) (4)
T cell cytokines in gut mucosa of patients with spondyloarthropathy reflect immune alterations in Crohn's disease (1999) (4)
Inflammatory Bowel Disease Spondyloarthritis: Epidemiology, Clinical Features, and Treatment (2006) (4)
Clinical assessment in the spondyloarthropathies, including psoriatic arthritis (2006) (4)
Enthesopathy of the heels in juvenile onset seronegative B27 positive spondyloarthropathy. (1986) (4)
Intestinal mucosa of patients with spondyloarthropathy is enriched with T cells carrying alpha E beta 7 integrin, even in the absence of histologically defined inflammation (1999) (3)
Ileocolonoscopy and spondarthritis. (1988) (3)
Belgian patients with familial and sporadic ankylosing spondylitis differ in disease phenotype (2006) (3)
Side-effects of levamisole: recent aspects (1987) (3)
Tumor necrosis factor-α blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification? (2005) (3)
[A study of the loss of occult blood by the method of radioactive chrome during treatment with acetylsalicylic acid. Effect of enclosure in cellulose acetylphthalate]. (1975) (3)
Juvenile spondyloarthropathies in 1992. (1993) (2)
Association between ASCA-positivity and carrier of a CARD-15 mutation in patients with Crohn's disease (2003) (2)
Classification models for disease: the effect of associations between markers on calculating the risk for disease by likelihood ratio products. (2009) (2)
Immunopathogenetic mechanisms in spondylarthropathy and gut inflammation. (1995) (2)
Rapidly growing gastric metastasis of Merkel cell carcinoma, an unusual cause of melena (2016) (2)
Eular workshop on Rheumatology Research (1982) (2)
T.9. Systemic Levels of IL-23 are Strongly Associated with Disease Activity in Rheumatoid Arthritis but not Spondyloarthritis (2009) (2)
HLA and juvenile chronic polyarthritis. (1976) (2)
A genetic acro-osteolysis syndrome. A Hajdu-Cheney syndrome. (1978) (2)
Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Attrition and long-term clinical effect (2006) (2)
Second conference on spondylarthropathies and the gut. (1994) (2)
2nd Conference on spondylarthropathies and the gut, Gent, Belgium, 1-2 July 1993 (1994) (2)
Reflections on the link between intestinal permeability and inflammatory joint disease. (1990) (2)
Clinical aspects of enterogenic arthropathies (1997) (2)
Agreement between evidence and Belgian rheumatologists' experience on the use of DMARDs for arthritis and/or enthesitis in ankylosing spondylitis (2008) (2)
Cervical septic spondylodiscitis in association with diffuse idiopathic skeletal hyperostosis. (1999) (2)
Salicylate-induced occult gastrointestinal blood loss: comparison between different oral and parenteral forms of acetylsalicylates and salicylates (1984) (2)
Longterm evaluation of intermittent levamisole treatment in rheumatoid arthritis. (1977) (2)
Arthritis and abdominal symptoms (1994) (1)
not spondyloarthritis with disease activity in rheumatoid arthritis but Systemic levels of IL-23 are strongly associated (2010) (1)
To be or not to be rheumatologist: survey among Belgian medical students and internal medicine trainees: what do certified rheumatologists think about the current rheumatology training program? (2017) (1)
Hajdu-Cheney syndrome. (2001) (1)
Agreement between evidence and Belgian rheumatologists' experience on HLA B27 determination in patients with specific imaging features in ankylosing spondylitis (2008) (1)
Lymphocyte sub-population counts after a single 40 mg administration of piroxicam in 20 patients with rheumatoid arthritis (1984) (1)
[Early referral of first line patients suspected of axial spondyloarthritis: the Belgian results of the RADAR study]. (2012) (1)
Lymphoepithelial interactions in human terminal ileum and colon : Electron-microscopic findings in normal and inflamed mucosa (1989) (1)
Comparing 2 referral strategies to diagnose axial spondyloarthritis: the recognizing and diagnosing ankylosing spondylitis reliably study (2011) (1)
International Congress on Spondyloarthropathies (2008) (1)
Short and long term synovial immunumodulation by etanercept in spondyloarthropathy (2005) (1)
Images in rheumatology: cervical septic spondylodiscitis in association with diffuse idiopathic skeletal hyperostosis. (1999) (1)
M2045 Reduced Metallothionein Expression in Colonic Crohn's Disease: Evidence for a New Disease-Modifying Gene (2008) (1)
Intrications of connective tissue diseases. (1978) (1)
Crohn's disease patients with CARD15 variants have higher risk of developing axial joint involvement (2003) (1)
Third Eular Workshop on Rheumatology Research (1983) (1)
Preliminary evidence for a retardation of structural damage in patients with ankylosing spondylitis continuously treated with infliximab for 4 years (2005) (1)
ISSAS: International Start TNF-blocker Study in Ankylosing Spondylitis (2004) (1)
Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition. (2006) (1)
Intra-articular treatment of inflammatory arthritis: Double-blind trial comparing bufexamac with methylprednisolone acetate (1987) (1)
Upregulation of E-cadherin and associated molecules (α-, β-, and γ-catenins) in inflammed bowel mucosa (1998) (1)
Bowel inflammation in rheumatic diseases: Trigger or consequence (2005) (1)
Effective immunomodulation of peripheral joint pathology in spondyloarthropathy by etanercept (2005) (1)
Influence of longterm administration of levamisole on total lymphocyte and T cell subsets in rheumatoid arthritis. (1984) (1)
The SF-6D differentiates less in the lower ranges of the patient's utility when compared with the EQ-5D but has a better reliability and sensitivity to change (2005) (1)
Strontium 87mscanning ofthesacroiliac joints inankylosing spondylitis (1972) (1)
Interferon-Gamma in the treatment of rheumatoid arthritis (1996) (1)
Effects of chemical agents and enzymes on the detection of lymphocyte surface markers. (1998) (0)
Isolation of colonie mucosal lamina propria and intra-epithelial lymphocytes: mechanical versus enzymatic isolation (1998) (0)
Inflammatory arthropathy and inflammatory bowel disease (1999) (0)
[Osteopoikilosis. 3 cases. Association with rheumatoid polyarthritis]. (1971) (0)
Prediction models for disease: The effect of associations between markers on calculating the risk for disease by likelihood ratio products in SpA (2008) (0)
A double-blind study to determine the duration of action of flurbiprofen in a sustained release preparation. (1993) (0)
Spondylarthropathy and the gut : the pathologist's contribution (1993) (0)
[Nonsurgical treatment of infectious arthritis caused by commonplace bacteria]. (1976) (0)
Clinical Characteristics and Functional Outcome Spinal Radiographic Changes in Ankylosing Spondylitis : Association with DEWULF (2009) (0)
The zygoapophyseal joint decides on the morphology of the enthesiophytes (1996) (0)
Relative increase of IL-10 producing peripheral blood T lymphocytes after anti-TNF-A chimeric antibody (infliximab) treatment in fistulizing Crohn's disease (2000) (0)
Gastrointestinal blood loss after intake of benoxaprofen (1982) (0)
Effects of anti-tumor necrosis factor alpha on synovium in patients with spondylarthropathy: Comment on the article by Baeten et al - Reply. (2001) (0)
T-Cell Subpopulations in Peripheral Blood and Synovial Fluid in Rheumatic Diseases (1984) (0)
opinion including uncertainty appraisal (part I): classification of paper patients by expert classification criteria for axial spondyloarthritis SpondyloArthritis international Society The development of Assessment of (2009) (0)
Contents, Vol. 189, Supplement 2, 1994 (1994) (0)
Comparison of different permeability probes in patients with spondylarthropathy and noninflammatory rheumatic disease: What is the effect of NSAIDs? (1998) (0)
Gut inflammation and rheumatology (1996) (0)
Evaluation of dual-energy absorptiometry (DXA) procedures for densitometry of hand bones in vitro and vivo (1992) (0)
Gut involvement in the spondyloarthritides (2010) (0)
Immunohistological studies of IL-2 receptor in normal and inflamed ileal mucosa (1992) (0)
Different cytokine profiles in peripheral blood and mucosal T lymphocytes of normal controls, Crohn's disease and ulcerative colitis patients (2000) (0)
First International Congress on Spondyloarthropathies, September 22-28, 1998, Gent, Belgium (1998) (0)
High frequency of 'missed' HLA-B loci by serologic determination in patients with spondyloarthropathy and chronic gut inflammation (1999) (0)
Ileocolonoscopy in patients with spondylarthropathy (1993) (0)
[Current findings on the immunological monitoring of patients with rheumatoid arthritis]. (1984) (0)
I n fluence of the gut and cytokine pat t e rns in spondy l o a rt h ro p at hy (2002) (0)
Mechanical isolation of human intestinal intraepithelial and lamina propria lymphocytes (1998) (0)
Rheumatic disorders in a HLA B27 positive population. (1979) (0)
[Joint manifestations of enteropathies]. (1993) (0)
Disease evolution in spondylarthropathy patients in relation to their gut histology on ileocolonoscopy (1993) (0)
SAT0274 High frequency of microscopic gut inflammation in axial and peripheral spondyloarthritis: The giant cohort (2013) (0)
Rheumatic disorders in a HLA B27 positive population. (1979) (0)
Inflammatory bowel disease and subclinical gut inflammation in spondyloarthropathy patients are associated with increased expression of the E-cadherin/catenin complex (1999) (0)
Maljor histocompatibili ty complex class IIantigen (HLA-DR)expression byileal epithelial cells in patients withseronegative spondylarthropathy (2011) (0)
[The non-surgical treatment of common bacterial infections of joints (author's transl)]. (1976) (0)
Clinical responsetotherapy withthymopoietin pentapeptide (TP-5) inrheumatoid arthritis (1982) (0)
IX Eular Workshop for Rheumatology Research (1989) (0)
SAT0235 Determinants of productivity costs in as. comparative study in the netherlands, france and belgium (2001) (0)
Spondyloarthropathies, involvement of the gut : proceedings of the First Conference on Spondyloarthropathies, Involvement of the Gut, Ghent, 10-13 September 1986 (1987) (0)
Long-term (up to 8 years) evaluation of side-effects of gold salts, levamisole and D-penicillamine in rheumatoid arthritis patients (1987) (0)
Sulfasalazine in "intractable" rheumatoid arthritis. (1987) (0)
[Levamisole used in rheumatoid arthritis]. (1979) (0)
Review of immunotherapy in rheumatoid arthritis (1980) (0)
SpondyloArthritis international Society (ASAS) exercise by experts from the Assessment of patients with chronic back pain: a real patient New criteria for inflammatory back pain in (2009) (0)
Clinical aspects of spondylarthritis: what is new ? (1995) (0)
Rheumatological manifestations of the enteropathies (1997) (0)
CHAPTER 88 – Spondyloarthropathies (2009) (0)
Molecular concepts in the approach to therapy (1992) (0)
T-cell receptors in ileal mucosal biopsies of patients with Crohn disease and spondylarthropathy. (1992) (0)
A RED FACE IN A LUPUS PATIENT: THINKING BEYOND LUPUS RASH (2010) (0)
Effects of chemical agents and enzymes on lymphocyte surface markers (1999) (0)
[HL-A and chronic juvenile polyarthritis]. (1976) (0)
Radiological sacroiliitis is linked with CARD15 gene polymorphisms in patients with Crohn's disease (2004) (0)
Evaluation of the DAS28 at week 14 or week 22 correlates best with long term attrition to infliximab therapy in rheumatoid arthritis patients (2006) (0)
Crohn's disease and ulcerative colitis show different distribution patterns of CD83 positive dendritic cells (1999) (0)
Increased expression of E 7 integrin in uninflamed mucosa of patients with spondyloarthropathy (1998) (0)
[Relationship between avascular necrosis and lipid and purine metabolisms]. (1975) (0)
Prognostic factors in the evolution of spondylarthropathies (1995) (0)
[Hematologic side effects of levamisole in the treatment of rheumatoid arthritis]. (1979) (0)
How to evaluate the DAS28 in patients with a false high score for reasons other than rheumatoid arthritis disease activity (2006) (0)
Gut inflammation in the spondylarthropathies : relation to the clinical expression of the disease and possible mechanisms (1992) (0)
EXPRESSION IN COLONIC CROHN'S DISEASE: EVIDENCE FOR A NEW DISEASE-MODIFYING GENE STUDY OF MUCOSAL ANTIMICROBIAL PEPTIDES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND AFTER (2008) (0)
Long-term follow-up in the treatment of rheumatoid arthritis with levamisole. (1981) (0)
Management of early inflammatory arthritis. Intervention with immunomodulatory agents: new pharmacological developments. (1992) (0)
[New prospects of immunotherapy in rheumatoid polyarthritis]. (1990) (0)
Flow cytometric determination of cytokine profile of peripheral blood and mucosal T lymphocytes in patients with fistulizing and non-fistulizing Crohn's disease (2000) (0)
THU0365 Work Productivity in a Cohort of Employed Ankylosing Spondylitis Patients Treated with Etanercept (2013) (0)
Chapter 18 – Enteric Infections and Arthritis (2007) (0)
Modeling the probability for rheumatoid arthritis during diagnostic work-up: How to combine the results of ACPA, RF and HLA-SE testing? (2006) (0)
A Comparison of TNF Dependent and Independent Features of Murine Spondyloarthropathy (2007) (0)
Influence of NSAID on intestinal permeability is dependent on the type of underlying rheumatic disease (1998) (0)
Diagnostic performance and predictive value of serum markers for the diagnosis of rheumatoid arthritis (2004) (0)
Ankylosing Spondylitis. Edited by M. Dougados and D. van der Heijde. £12.00. Oxford, Health Press, 2004. 84 pp. ISBN 1-903734-44-4. (2004) (0)
Radiological sacroiliitis in Crohn's disease: A multicenter association study (2006) (0)
Ileitis in rheumatic diseases (1995) (0)
Assessment of agreement of expert opinion on clinical features in axial spondyloarthritis (SpA) (2005) (0)
DAS28 is a robust measure of the physician's clinical judgment of response infliximab therapy (2005) (0)
Occurrence and 2-year progression of syndesmophytes in a prevalence cohort of patients with ankylosing spondylitis (AS) (2005) (0)
Arthritis, osteoporosis and rheumatologic manifestations: patterns, diagnostic and therapeutic problems (1998) (0)
[Determination of immunoglobulins G, M and A in synovial fluid]. (1971) (0)
Which patients with ankylosing spondylitis start anti-TNF-alpha therapy in daily clinical practice? (2006) (0)
Second conference on spondylarthropathies and the gut - meeting report (1994) (0)
AB0233 Productivity costs in as. comparison among 3 european countries (2001) (0)
Parameters contributing to inflammatory back pain (IBP) according to experts (2005) (0)
Clinical trials on the efficacy and toxicity of slow acting antirheumatic drugs. (1984) (0)
INCREASED INTESTINAL PERMEABILITY IN ANKYLOSING SPONDYLITIS. AUTHOR'S REPLY (1992) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Herman Mielants?

Herman Mielants is affiliated with the following schools:

Ghent University